Episode 152: Myeloma Capstone, Pt 1 - Smolder...

In this week’s episode, we continue our journey through the relapsed/refractory myeloma space, with a focus on the role of bispecific T-cell engagers. Another incredibly important conversation that is so important in the current treatment landscape and one that you don’t want to ...  Afficher plus

In this week’s episode, we take a practical dive into the relapsed/refractory myeloma space, with a focus on the role of CAR T therapy for relapsed/refractory. In our next episode, we will continue on with a discussion on bispecific agents! This is a conversation that is so impor ...  Afficher plus

In this podcast, I continue to delve into MSK concepts the USMLEs consider to be relevant for Step 1-3 by discussing NBME pathologies relating to the knees and hip. Short podcast but very HY for your test. Audio Download 

In this episode, Dr. Nazim Gherabi (DZ) discusses his systematic review on the treatment of urge incontinence in postmenopausal women.

Dr. Gherabi talks about the most effective therapeutic approaches, and evaluates current evidence. He highlights gaps in research and ...

This is one of my highest yield rapid review podcasts. In this episode, I discuss a lot of concepts relating to multi systems processes and disorders. I take one disorder and make so many common exam integrations while paying attention to pathophysiology. Please listen to this ah ...  Afficher plus

Joseph Mikhael, MD, and Krina K. Patel, MD, MSc, discuss considerations for CAR T-Cell therapy in multiple myeloma, including age, access, and bridging therapy. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002715. ...  Afficher plus